DrugPatentWatch Database Preview
Sun Pharm Inds Ltd Company Profile
What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?
SUN PHARM INDS LTD has one hundred and seventeen approved drugs.
There are eight US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.
There are thirty-one patent family members on SUN PHARM INDS LTD drugs in nineteen countries and one hundred and thirty-nine supplementary protection certificates in thirteen countries.
Summary for Sun Pharm Inds Ltd
| International Patents: | 31 |
| US Patents: | 8 |
| Tradenames: | 90 |
| Ingredients: | 87 |
| NDAs: | 117 |
Drugs and US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | AMOXICILLIN | amoxicillin | FOR SUSPENSION;ORAL | 065113-002 | Nov 29, 2002 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Sun Pharm Inds Ltd | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 077058-001 | Sep 10, 2007 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Sun Pharm Inds Ltd | LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 091382-001 | Apr 20, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078722-002 | May 12, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 091200-003 | Dec 13, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Sun Pharm Inds Ltd
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,559,187 | Liquid formulation of metformin | ➤ Sign Up |
| 9,192,615 | Method for the treatment of acne and certain dosage forms thereof | ➤ Sign Up |
| 8,722,650 | Extended-release minocycline dosage forms | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Sun Pharm Inds Ltd Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Israel | 188331 | ➤ Sign Up |
| Iceland | 6709 | ➤ Sign Up |
| New Zealand | 524519 | ➤ Sign Up |
| Mexico | PA03001157 | ➤ Sign Up |
| Russian Federation | 2003104808 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 30/2006 | Austria | ➤ Sign Up | PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SÄUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN |
| 90013-0 | Sweden | ➤ Sign Up | PRODUCT NAME: SAXAGLIPTIN/METFORMIN; REG. NO/DATE: EU/1/11/731/001 20111124 |
| C/GB98/013 | United Kingdom | ➤ Sign Up | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
| 1261586/02 | Switzerland | ➤ Sign Up | PRODUCT NAME: SAXAGLIPTIN UND METFORMIN; NAT. REGISTRATION NO/DATE: SWISSMEDIC 62040 20120329 |
| 128 | Luxembourg | ➤ Sign Up | PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3, 7-DIHYDROPURIN-2, 6-DION, LES ENANTIOMERES ET LEURS SELS, EN PARTICULIER LA LINAGLIPTINE COMBINEE AVEC DU CHLORHYDRATE DE METFORMINE. LINAGLIPTINE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
